GIM
SCMP

Granahan Investment Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Granahan Investment Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,614,074
Closed -$32.1M – 257
2015
Q3 		$32.1M Buy
1,614,074
+54,830
+4% +$1.26M 0.99% 23
2015
Q2 		$25.6M Sell
1,559,244
-461,320
-23% -$8M 0.73% 47
2015
Q1 		$31.4M Buy
2,020,564
+660,230
+49% +$10.2M 0.9% 33
2014
Q4 		$19.4M Sell
1,360,334
-29,441
-2% -$311K 0.57% 68
2014
Q3 		$9.03M Buy
1,389,775
+133,186
+11% +$885K 0.28% 120
2014
Q2 		$8.67M Sell
1,256,589
-38,800
-3% -$274K 0.25% 130
2014
Q1 		$9.26M Buy
1,295,389
+123,990
+11% +$1.06M 0.25% 140
2013
Q4 		$11M Buy
1,171,399
+26,600
+2% +$190K 0.28% 127
2013
Q3 		$7.14M Buy
1,144,799
+33,230
+3% +$208K 0.19% 153
2013
Q2 		$7.31M Buy
+1,111,569
New +$8.82M 0.21% 148

Other funds holding SCMP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Granahan Investment Management's SCMP Position: Q4 2015 in Review

Granahan Investment Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2015, closing a stake of 1,614,074 shares — an estimated $32.1M sold.

Granahan Investment Management first reported a position in SCMP in Q2 2013 and held it in 10 quarters. The position peaked at $32.1M in Q3 2015. 149 funds tracked by Wall St. Rank hold SCMP as of Q4 2015.

  • Granahan Investment Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Granahan Investment Management sold 1,614,074 Sucampo Pharmaceuticals, Inc. shares in Q4 2015, an estimated $32.1M.
  • Granahan Investment Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 10 quarters.
  • Granahan Investment Management's Sucampo Pharmaceuticals, Inc. position peaked at $32.1M in Q3 2015.
  • 149 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2015.

Based on Granahan Investment Management's 13F filing for Q4 2015, filed 12 Feb 2016.